BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26444645)

  • 1. The Incidence of Gastric Adenocarcinoma Among Patients With Gastric Intestinal Metaplasia: A Long-term Cohort Study.
    Lee TY; Wang RC; Lee YC; Lin JT; Ho HJ; Hsieh MC; Wu CY
    J Clin Gastroenterol; 2016 Aug; 50(7):532-7. PubMed ID: 26444645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
    de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ
    Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer: results of the Spanish follow-up multicenter study.
    González CA; Sanz-Anquela JM; Companioni O; Bonet C; Berdasco M; López C; Mendoza J; Martín-Arranz MD; Rey E; Poves E; Espinosa L; Barrio J; Torres MÁ; Cuatrecasas M; Elizalde I; Bujanda L; Garmendia M; Ferrández Á; Muñoz G; Andreu V; Paules MJ; Lario S; Ramírez MJ; ; Gisbert JP
    J Gastroenterol Hepatol; 2016 May; 31(5):953-8. PubMed ID: 26630310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Risk of Progression to Gastric Adenocarcinoma in Patients with Non-dysplastic Gastric Intestinal Metaplasia Versus a Control Population.
    Dhingra R; Natov NS; Daaboul Y; Guelrud M; Cherukara A; Hung PF; Sterling MJ
    Dig Dis Sci; 2020 Nov; 65(11):3316-3323. PubMed ID: 31916085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks and Predictors of Gastric Adenocarcinoma in Patients with Gastric Intestinal Metaplasia and Dysplasia: A Population-Based Study.
    Li D; Bautista MC; Jiang SF; Daryani P; Brackett M; Armstrong MA; Hung YY; Postlethwaite D; Ladabaum U
    Am J Gastroenterol; 2016 Aug; 111(8):1104-13. PubMed ID: 27185078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review.
    Spence AD; Cardwell CR; McMenamin ÚC; Hicks BM; Johnston BT; Murray LJ; Coleman HG
    BMC Gastroenterol; 2017 Dec; 17(1):157. PubMed ID: 29228909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal metaplasia of the gastric cardia.
    Morales TG; Sampliner RE; Bhattacharyya A
    Am J Gastroenterol; 1997 Mar; 92(3):414-8. PubMed ID: 9068460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for metachronous gastric carcinoma development after endoscopic resection of gastric dysplasia: Retrospective, single-center study.
    Moon HS; Yun GY; Kim JS; Eun HS; Kang SH; Sung JK; Jeong HY; Song KS
    World J Gastroenterol; 2017 Jun; 23(24):4407-4415. PubMed ID: 28706423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric cancer occurrence in preneoplastic lesions: a long-term follow-up in a high-risk area in Spain.
    González CA; Pardo ML; Liso JM; Alonso P; Bonet C; Garcia RM; Sala N; Capella G; Sanz-Anquela JM
    Int J Cancer; 2010 Dec; 127(11):2654-60. PubMed ID: 20178099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of intestinal metaplasia as a predictor of gastric cancer development.
    Shichijo S; Hirata Y; Sakitani K; Yamamoto S; Serizawa T; Niikura R; Watabe H; Yoshida S; Yamada A; Yamaji Y; Ushiku T; Fukayama M; Koike K
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1260-4. PubMed ID: 25777777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication.
    Shichijo S; Hirata Y; Niikura R; Hayakawa Y; Yamada A; Ushiku T; Fukayama M; Koike K
    Gastrointest Endosc; 2016 Oct; 84(4):618-24. PubMed ID: 26995689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Gastric Cancer Among Patients With Intestinal Metaplasia of the Stomach in a US Integrated Health Care System.
    Reddy KM; Chang JI; Shi JM; Wu BU
    Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1420-5. PubMed ID: 27317852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up of premalignant lesions in patients at risk for progression to gastric cancer.
    den Hoed CM; Holster IL; Capelle LG; de Vries AC; den Hartog B; Ter Borg F; Biermann K; Kuipers EJ
    Endoscopy; 2013; 45(4):249-56. PubMed ID: 23533073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of gastric precancerous conditions: a systematic review and meta-analysis.
    Marques-Silva L; Areia M; Elvas L; Dinis-Ribeiro M
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):378-87. PubMed ID: 24569821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric cancer risk according to the distribution of intestinal metaplasia and neutrophil infiltration.
    Sakitani K; Hirata Y; Watabe H; Yamada A; Sugimoto T; Yamaji Y; Yoshida H; Maeda S; Omata M; Koike K
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1570-5. PubMed ID: 21575058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of DNA flow cytometry in the diagnosis, risk stratification, and management of gastric epithelial dysplasia.
    Wen KW; Rabinovitch PS; Huang D; Mattis AN; Lauwers GY; Choi WT
    Mod Pathol; 2018 Oct; 31(10):1578-1587. PubMed ID: 29789650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking and Urinary Cotinine Levels Are Predictors of Increased Risk for Gastric Intestinal Metaplasia.
    Kim K; Chang Y; Ahn J; Yang HJ; Jung JY; Kim S; Sohn CI; Ryu S
    Cancer Res; 2019 Feb; 79(3):676-684. PubMed ID: 30563886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Neoplastic Progression Among Patients with an Irregular Z Line on Long-Term Follow-Up.
    Itskoviz D; Levi Z; Boltin D; Vilkin A; Snir Y; Gingold-Belfer R; Niv Y; Dotan I; Dickman R
    Dig Dis Sci; 2018 Jun; 63(6):1513-1517. PubMed ID: 29327262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
    Wong BC; Lam SK; Wong WM; Chen JS; Zheng TT; Feng RE; Lai KC; Hu WH; Yuen ST; Leung SY; Fong DY; Ho J; Ching CK; Chen JS;
    JAMA; 2004 Jan; 291(2):187-94. PubMed ID: 14722144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The accuracy of flexible spectral imaging colour enhancement for the diagnosis of gastric intestinal metaplasia: do we still need histology to select individuals at risk for adenocarcinoma?
    Kikuste I; Stirna D; Liepniece-Karele I; Leja M; Dinis-Ribeiro M
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):704-9. PubMed ID: 24901816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.